MCOV B — Medicover AB Income Statement
0.000.00%
Last trade - 00:00- SEK33.14bn
- SEK47.86bn
- €2.09bn
- 83
- 19
- 67
- 58
Annual income statement for Medicover AB, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 998 | 1,377 | 1,510 | 1,746 | 2,092 |
| Cost of Revenue | |||||
| Gross Profit | 264 | 395 | 340 | 359 | 448 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 937 | 1,218 | 1,455 | 1,677 | 2,022 |
| Operating Profit | 61.3 | 159 | 55.5 | 69.2 | 70.3 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 37.3 | 144 | 19.8 | 23.6 | 20.1 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 27.3 | 107 | 14 | 18.4 | 14.6 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | 25.8 | 102 | 12.1 | 17.6 | 16.7 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 25.8 | 102 | 12.1 | 17.6 | 16.7 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 0.255 | 0.737 | 0.146 | 0.08 | 0.371 |
| Dividends per Share |